199 related articles for article (PubMed ID: 18312352)
1. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of the ATBF1 gene in gastric cancer.
Cho YG; Song JH; Kim CJ; Lee YS; Kim SY; Nam SW; Lee JY; Park WS
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4355-9. PubMed ID: 17671116
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
Kanai Y; Hui AM; Sun L; Ushijima S; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1999 Mar; 29(3):703-9. PubMed ID: 10051471
[TBL] [Abstract][Full Text] [Related]
5. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
[TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
[TBL] [Abstract][Full Text] [Related]
8. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
Matsumura T; Makino R; Mitamura K
Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.
Ninomiya T; Mihara K; Fushimi K; Hayashi Y; Hashimoto-Tamaoki T; Tamaoki T
Hepatology; 2002 Jan; 35(1):82-7. PubMed ID: 11786962
[TBL] [Abstract][Full Text] [Related]
12. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew M; Smith JL; Jass JR; Young J; Leggett BA; Macdonald GA
Oncol Rep; 2007 Apr; 17(4):817-22. PubMed ID: 17342321
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma.
Yamamoto Y; Sakamoto M; Fujii G; Kanetaka K; Asaka M; Hirohashi S
Clin Cancer Res; 2001 Feb; 7(2):297-303. PubMed ID: 11234883
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
15. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
[TBL] [Abstract][Full Text] [Related]
17. Genetic and expression analysis of the KCNRG gene in hepatocellular carcinomas.
Cho YG; Kim CJ; Song JH; Rhie DJ; Park YK; Kim SY; Nam SW; Yoo NJ; Lee JY; Park WS
Exp Mol Med; 2006 Jun; 38(3):247-55. PubMed ID: 16819283
[TBL] [Abstract][Full Text] [Related]
18. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Peng SY; Ou YH; Chen WJ; Li HY; Liu SH; Pan HW; Lai PL; Jeng YM; Chen DC; Hsu HC
Int J Oncol; 2005 Apr; 26(4):1053-61. PubMed ID: 15754002
[TBL] [Abstract][Full Text] [Related]
20. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.
Sun X; Frierson HF; Chen C; Li C; Ran Q; Otto KB; Cantarel BL; Vessella RL; Gao AC; Petros J; Miura Y; Simons JW; Dong JT
Nat Genet; 2005 Apr; 37(4):407-12. PubMed ID: 15750593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]